Breast cancer – where are we standing in 2011?

Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 2

Abstract

Breast cancer is one of the major health and social problems in women. Due to the wide application of screening programs and to improvements in treatment, breast cancer mortality in some countries has decreased by more than 30% over the last twenty years. Advances in breast cancer management include also the decreasing negative impact of therapy on patients’ quality of life. This is mostly achieved by substituting major, mutilating surgery with organ-sparing or reconstructive procedures. The progress in systemic treatment of breast cancer is mostly related to the developments in molecular biology and a better understanding of breast cancer pathomechanisms, including identification of molecular subtypes of breast cancer by multigene assays. This has led to a profound modification of treatment strategies in early breast cancer. Failure risk has now been substituted as the main factor driving treatment decision-making by biology of tumor and likely sensitivity to particular treatment modalities. Most important achievements include also the development of trastuzumab and lapatinib – molecularly “targeted” compounds directed against HER2. Development of targeted therapy includes not only designing targeted agents but also identification of constitutive predictive features of particular patients, which may allow individual tailoring of systemic therapies. Among these, most interest is raised by polymorphisms of the cytochrome P450 2D6 – an enzyme involved in the metabolism of tamoxifen. Ongoing research will hopefully result in further improvements in prognosis and quality of life of breast cancer patients.

Authors and Affiliations

Elżbieta Senkus, Jacek Jassem

Keywords

Related Articles

Nowe kierunki badań nad profilaktyką powikłań zatorowych u chorych z migotaniem przedsionków. Udział Kliniki Kardiologii CMKP w wieloośrodkowych badaniach klinicznych

Migotanie przedsionków (AF) jest najczęstszą arytmią przedsionkową. AF nieleczone lub leczone niewłaściwie wiąże się ze zwiększoną śmiertelnością. Częstość występowania zarówno AF, jak i udaru mózgu wzrasta z wiekiem. Ud...

The emergence of carbohydrate metabolism disorders in the course of pancreatic adenocarcinoma (PC) and chronic pancreatitis (CP) – assessment of insulin level and insulin resistance

Introduction. The incidence of carbohydrate metabolism disorders is estimated at approximately 10-35% of patients diagnosed with chronic pancreatitis (CP) and approximately 40-80% of patients diagnosed with adenocarcinom...

The impact of hormonal treatment on the development of the hip in multiple pregnancy – sonographic assessment

<b>Introduction.</b> An increasing number of multiple pregnancies have been observed within the last twenty years. Multiple pregnancies occur more often in families that have had twins before,...

Neuronal channelopathies

Ion channels are specialized proteins of the cell membrane which transports ions across the membrane. Ion channels are widely expressed both in excitable cells (neurons, muscles) and in the other cells (renal tubules, ep...

Breast reduction surgery of hypertrophic and sagging breasts in the material from the Plastic Surgery Clinic of the Postgraduate Education Centre in Warsaw

Introduction. Significant breast hypertrophy and ptosis is a medical indication for surgical treatment. Patients seek help because of vertebral diseases, painful bra grooving and inframammary rashes.Aim. The aim of the s...

Download PDF file
  • EP ID EP54116
  • DOI -
  • Views 140
  • Downloads 0

How To Cite

Elżbieta Senkus, Jacek Jassem (2011). Breast cancer – where are we standing in 2011?. Postępy Nauk Medycznych, 24(2), -. https://europub.co.uk/articles/-A-54116